Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole as adjunct to citalopram for major depressive disorder
IRCT201312263930N30Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pramipexole in major depressive disorder (MDD), sponsored by Shiraz University of Medical Sciences. Started Oct 2013; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201312263930N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312263930N30.